cefuroxime has been researched along with Bacterial Pneumonia in 43 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cefuroxime axetil is an oral cephalosporin with proven efficacy in adult lower respiratory tract infections." | 5.29 | [Treatment of bacterial pneumonias with cefuroxime-axetil. Predictive value of measurement of the in vitro susceptibility]. ( Cluzel, R; Modaï, J; Portier, H, 1996) |
| " The sensitivity of clinically significant 96 strains from patients with pyelonephritis and 180 strains from patients with lower respiratory tract infections (pneumonia, COPD) was compared for cefuroxime and cefotaxime or ceftriaxone according NCCLS recommendations during 2000-2001 years." | 3.72 | [Microbiological evaluation of differences between cephalosporins of second and third generations in general hospital]. ( Bogdanov, MB; Chernen'kaia, TV, 2003) |
| " The clinical picture of a "typical" bacterial pneumonia in the three patients led to an initial empirical treatment with amoxicillin clavulanic acid or 2(nd) generation cephalosporins." | 3.69 | Severe community-acquired pneumonia caused by atypical organisms. ( Huyghens, L; Lauwers, S; Meysman, M; Monsieur, I; Vincken, W, 1997) |
| " Adverse events were recorded in 38." | 2.71 | Clinical efficacy and safety of a short regimen of azithromycin sequential therapy vs standard cefuroxime sequential therapy in the treatment of community-acquired pneumonia: an international, randomized, open-label study. ( Banaszak, AM; Daković-Rode, O; Kuzman, I; Oremus, M, 2005) |
| " The clinical and bacteriological efficacies and pharmacokinetic properties of both the dosage forms were estimated." | 2.69 | [Stepwise therapy of community-acquired pneumonia. Results of cefuroxime and cefuroxime axetil study]. ( Dvoretskiĭ, LI; Iakovlev, SV; Shakhova, TV; Suvorova, MP; Vlasenko, NA, 1998) |
| "Cefuroxime axetil has been evaluated previously in the treatment of lower respiratory tract infections, but not specifically in the treatment of community-acquired pneumonia." | 2.68 | Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia. ( Collins, JJ; Feris, J; Giguere, G; Hidalgo, H; Higuera, F, 1996) |
| " Drug-related adverse events were reported in 5." | 2.68 | A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia. ( Dunbar, L; File, TM; Kohler, R; Kojak, C; Player, R; Rubin, A; Segreti, J; Williams, RR, 1997) |
| "Bacterial pneumonia is a very common cause of morbidity and mortality among persons with human immunodeficiency virus; however, the microbiologic characteristics (including antibiotic resistance) of bacterial pathogens causing community-acquired pneumonia in this population have not been well characterized or correlated with potentially predictive clinical presentation characteristics." | 1.29 | Microbiology of community-acquired bacterial pneumonia in persons with and at risk for human immunodeficiency virus type 1 infection. Implications for rational empiric antibiotic therapy. ( Burack, JH; Hahn, JA; Jacobson, MA; Saint-Maurice, D, 1994) |
| "Cefuroxime axetil is an oral cephalosporin with proven efficacy in adult lower respiratory tract infections." | 1.29 | [Treatment of bacterial pneumonias with cefuroxime-axetil. Predictive value of measurement of the in vitro susceptibility]. ( Cluzel, R; Modaï, J; Portier, H, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (4.65) | 18.7374 |
| 1990's | 21 (48.84) | 18.2507 |
| 2000's | 15 (34.88) | 29.6817 |
| 2010's | 5 (11.63) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breuer, O | 1 |
| Blich, O | 1 |
| Cohen-Cymberknoh, M | 2 |
| Averbuch, D | 2 |
| Kharasch, S | 3 |
| Shoseyov, D | 1 |
| Kerem, E | 3 |
| Yayan, J | 1 |
| Ghebremedhin, B | 1 |
| Rasche, K | 1 |
| Dinur-Schejter, Y | 2 |
| Tenenbaum, A | 1 |
| Brooks, R | 1 |
| Korppi, M | 1 |
| Vitkauskiene, A | 1 |
| Sakalauskas, R | 1 |
| Dudzevicius, V | 1 |
| Bogdanov, MB | 2 |
| Chernen'kaia, TV | 2 |
| Holak, H | 1 |
| Becker, R | 1 |
| Holak, S | 1 |
| Barton, LL | 1 |
| Marrie, TJ | 1 |
| Barnes, NP | 1 |
| Hull, J | 1 |
| Thomson, AH | 1 |
| Meng, J | 1 |
| Xie, W | 1 |
| Wu, AH | 1 |
| Hu, CP | 1 |
| Wang, YJ | 1 |
| Spencer, RC | 1 |
| Nolen, TM | 1 |
| Hutchison, J | 1 |
| Phillips, HL | 1 |
| Kuzman, I | 1 |
| Daković-Rode, O | 1 |
| Oremus, M | 1 |
| Banaszak, AM | 1 |
| Allan, RC | 1 |
| Moghal, M | 1 |
| Wijesuriya, V | 1 |
| Melzer, M | 1 |
| Baltayiannis, N | 1 |
| Markogiannakis, A | 1 |
| Sfyridis, P | 1 |
| Manolis, EN | 1 |
| Anagnostopoulos, D | 1 |
| Bolanos, N | 1 |
| Hatzimichalis, A | 1 |
| Tsakris, A | 1 |
| Höffken, G | 1 |
| Barth, J | 1 |
| Rubinstein, E | 1 |
| Beckmann, H | 1 |
| Martin, M | 1 |
| Moore, L | 1 |
| Quilici, S | 1 |
| Decramer, M | 1 |
| Simoens, S | 1 |
| Maass, M | 1 |
| Dalhoff, K | 1 |
| Burack, JH | 1 |
| Hahn, JA | 1 |
| Saint-Maurice, D | 1 |
| Jacobson, MA | 1 |
| Cluzel, R | 1 |
| Portier, H | 1 |
| Modaï, J | 1 |
| Villuendas, C | 1 |
| Remacha, MA | 1 |
| Echávarri, B | 1 |
| Ferrer, J | 1 |
| Omeñaca, M | 1 |
| Aisa, ML | 1 |
| Gómez, J | 2 |
| Baños, V | 2 |
| Ruiz Gómez, J | 2 |
| Soto, MC | 2 |
| Muñoz, L | 2 |
| Nuñez, ML | 1 |
| Canteras, M | 2 |
| Valdés, M | 2 |
| Oh, HM | 1 |
| Ng, AW | 1 |
| Lee, SK | 1 |
| Bart, BIa | 1 |
| Solov'ev, SS | 1 |
| Zaseeva, OV | 1 |
| Benevskaia, VF | 1 |
| Mikhaĭlusova, MP | 1 |
| Romanova, MV | 1 |
| Kasatikova, LA | 1 |
| Sirvent, JM | 1 |
| Torres, A | 1 |
| El-Ebiary, M | 1 |
| Castro, P | 1 |
| de Batlle, J | 1 |
| Bonet, A | 1 |
| Higuera, F | 1 |
| Hidalgo, H | 1 |
| Feris, J | 1 |
| Giguere, G | 1 |
| Collins, JJ | 1 |
| Monsieur, I | 1 |
| Meysman, M | 1 |
| Vincken, W | 1 |
| Huyghens, L | 1 |
| Lauwers, S | 1 |
| Van den Brande, P | 1 |
| Vondra, V | 1 |
| Vogel, F | 1 |
| Schlaeffer, F | 1 |
| Staley, H | 1 |
| Holmes, C | 1 |
| Lim, TK | 1 |
| File, TM | 1 |
| Segreti, J | 1 |
| Dunbar, L | 1 |
| Player, R | 1 |
| Kohler, R | 1 |
| Williams, RR | 2 |
| Kojak, C | 2 |
| Rubin, A | 1 |
| Ribas, J | 1 |
| Lores, L | 1 |
| Ruiz, J | 1 |
| Ausina, V | 1 |
| Morera, J | 1 |
| Wessels, F | 1 |
| Anderson, AN | 1 |
| Ebrahim, O | 1 |
| Iakovlev, SV | 2 |
| Suvorova, MP | 2 |
| Dvoretskiĭ, LI | 2 |
| Vlasenko, NA | 1 |
| Shakhova, TV | 2 |
| Sánchez, ME | 1 |
| Gómez Vargas, J | 1 |
| Simarro, E | 1 |
| Mishra, A | 1 |
| Friedman, HS | 1 |
| Sinha, AK | 1 |
| Rovira, E | 1 |
| Martínez-Moragón, E | 1 |
| Belda, A | 1 |
| Gonzalvo, F | 1 |
| Ripollés, F | 1 |
| Pascual, JM | 1 |
| Ogle, JW | 1 |
| Rittenhouse, BE | 1 |
| Stinnett, AA | 1 |
| Dulisse, B | 1 |
| Henke, CJ | 1 |
| Potter, L | 1 |
| Parasuraman, B | 1 |
| Martens, LL | 1 |
| Adair, CG | 1 |
| Gorman, SP | 1 |
| Byers, LM | 1 |
| Jones, DS | 1 |
| Feron, B | 1 |
| Crowe, M | 1 |
| Webb, HC | 1 |
| McCarthy, GJ | 1 |
| Milligan, KR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Antibiotic Prophylaxis in Critically Ill Patients After Suspected Aspiration[NCT05079620] | Phase 4 | 100 participants (Anticipated) | Interventional | 2021-11-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for cefuroxime and Bacterial Pneumonia
| Article | Year |
|---|---|
[Slowly-evolving pneumonia in a 14-year-old boy].
Topics: Adolescent; Cefuroxime; Cephalosporins; Drug Resistance, Microbial; Eikenella corrodens; Gram-Negati | 1995 |
Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients. A pharmaco-economic study based on a meta-analysis.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosp | 1998 |
15 trials available for cefuroxime and Bacterial Pneumonia
| Article | Year |
|---|---|
Experience with levofloxacin in a critical pathway for the treatment of community-acquired pneumonia.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Ambulatory Care; Anti-Infective Agents; Azi | 2004 |
Medical management of parapneumonic pleural disease.
Topics: Adolescent; Anti-Bacterial Agents; Cefuroxime; Chest Tubes; Child; Child, Preschool; Double-Blind Me | 2005 |
Clinical efficacy and safety of a short regimen of azithromycin sequential therapy vs standard cefuroxime sequential therapy in the treatment of community-acquired pneumonia: an international, randomized, open-label study.
Topics: Anti-Bacterial Agents; Azithromycin; Cefuroxime; Community-Acquired Infections; Drug Administration | 2005 |
A randomized study of sequential intravenous/oral moxifloxacin in comparison to sequential intravenous ceftriaxone/oral cefuroxime axetil in patients with hospital-acquired pneumonia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compoun | 2007 |
Cefuroxime compared to amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.
Topics: Administration, Oral; Adult; Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clavula | 1996 |
[The use of the cephalosporin antibiotic Zinnat under polyclinic conditions in treating patients with bronchopulmonary infections].
Topics: Acute Disease; Adolescent; Adult; Ambulatory Care; Bronchitis; Cefuroxime; Cephalosporins; Chronic D | 1996 |
Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma.
Topics: Adult; Antibiotic Prophylaxis; Cefuroxime; Cephalosporins; Coma; Cross Infection; Female; Humans; In | 1997 |
Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium | 1996 |
Sequential therapy with cefuroxime followed by cefuroxime axetil in community-acquired pneumonia.
Topics: Administration, Oral; Cefuroxime; Cephalosporins; Community-Acquired Infections; Drug Administration | 1997 |
A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ceftriaxone | 1997 |
[Stepwise therapy of community-acquired pneumonia. Results of cefuroxime and cefuroxime axetil study].
Topics: Administration, Oral; Adolescent; Adult; Aged; Cefuroxime; Cephalosporin Resistance; Cephalosporins; | 1998 |
[Program of empirical antibacterial therapy of community-acquired pneumonia].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infect | 1998 |
[Prospective and comparative study between cefuroxime, ceftriaxone and amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Ceftriaxo | 1998 |
Treatment of community-acquired pneumonia in outpatients: randomized study of clarithromycin alone versus clarithromycin and cefuroxime.
Topics: Adult; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clarithromycin; Community-Acquired Infecti | 1999 |
An economic evaluation of levofloxacin versus cefuroxime axetil in the outpatient treatment of adults with community-acquired pneumonia.
Topics: Adult; Aged; Ambulatory Care; Anti-Infective Agents; Cefuroxime; Cephalosporins; Drug Costs; Evaluat | 2000 |
26 other studies available for cefuroxime and Bacterial Pneumonia
| Article | Year |
|---|---|
Antibiotic treatment for children hospitalized with community-acquired pneumonia after oral therapy.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Ambulatory Care; Amoxicillin; Ampicil | 2015 |
No Resistance to Penicillin, Cefuroxime, Cefotaxime, or Vancomycin in Pneumococcal Pneumonia.
Topics: Aged; Cefotaxime; Cefuroxime; Cephalosporin Resistance; Cross Infection; Drug Resistance, Bacterial; | 2015 |
Antibiotic treatment of children with community-acquired pneumonia: comparison of penicillin or ampicillin versus cefuroxime.
Topics: Ampicillin; Anti-Bacterial Agents; Cefuroxime; Child, Preschool; Community-Acquired Infections; Hosp | 2013 |
Intravenous penicillin--still the first-line therapy for pediatric community-acquired pneumonia.
Topics: Ampicillin; Anti-Bacterial Agents; Cefuroxime; Humans; Penicillins; Pneumonia, Bacterial | 2013 |
Reply: To PMID 22431471.
Topics: Ampicillin; Anti-Bacterial Agents; Cefuroxime; Humans; Penicillins; Pneumonia, Bacterial | 2013 |
[The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective | 2003 |
[Microbiological evaluation of differences between cephalosporins of second and third generations in general hospital].
Topics: Anti-Bacterial Agents; Bronchitis; Cefotaxime; Ceftriaxone; Cefuroxime; Gram-Negative Bacteria; Hosp | 2003 |
[Long-term follow-up of bilateral endogenous Klebsiella endophthalmitis].
Topics: Abscess; Aged; Cefotaxime; Cefuroxime; Drug Therapy, Combination; Endophthalmitis; Follow-Up Studies | 2003 |
Cefuroxime-induced immune hemolysis.
Topics: Anemia, Hemolytic; Anti-Bacterial Agents; Cefuroxime; Drug Hypersensitivity; Humans; Pneumonia, Bact | 2004 |
[Pathogens and drug resistance of nosocomial pneumonia after intracranial surgery].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin Resistance; Brain; Cefuroxime; Child; Child, | 2004 |
A comparison of cefuroxime axetil and amoxycillin in the treatment of lower respiratory tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bronchitis; Cefuroxi | 1989 |
A comparison of the safety and efficacy of cefuroxime axetil and cefaclor in outpatient management of community-acquired lower respiratory tract infections.
Topics: Alabama; Anti-Bacterial Agents; Bronchitis; Cefaclor; Cefuroxime; Clinical Trials as Topic; Communit | 1989 |
University-acquired pneumonia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Community-Acquired Infections; | 2006 |
The influence of local instillation of fusidic acid on the development of microbial complications after lung resection.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Bronchial Fistula; Carcin | 2006 |
A cost-effectiveness analysis of antimicrobial treatment of community-acquired pneumonia taking into account resistance in Belgium.
Topics: Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Belgium; Cefuroxime; Clarithromycin; Community-Ac | 2008 |
[Isolation of Chlamydia pneumoniae in atypical pneumonia].
Topics: Adult; Bronchoalveolar Lavage Fluid; Cefuroxime; Chlamydia Infections; Chlamydophila pneumoniae; Cla | 1994 |
Microbiology of community-acquired bacterial pneumonia in persons with and at risk for human immunodeficiency virus type 1 infection. Implications for rational empiric antibiotic therapy.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Ampicillin Resistance; Bacteria; Cefuroxime; Com | 1994 |
[Treatment of bacterial pneumonias with cefuroxime-axetil. Predictive value of measurement of the in vitro susceptibility].
Topics: Adolescent; Adult; Aged; Cefuroxime; Cephalosporins; Female; Haemophilus influenzae; Humans; Male; M | 1996 |
Prospective study of epidemiology and prognostic factors in community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Cephalosporins; Chlamydophi | 1996 |
Severe community-acquired pneumonia caused by atypical organisms.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefuroxime | 1997 |
Cefuroxime compared to amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Cephalosporins; Clavu | 1997 |
Pancoast's syndrome due to chronic pneumonia by Pasteurella multocida.
Topics: Adult; Cefuroxime; Cephalosporins; Chronic Disease; Diagnosis, Differential; Humans; Male; Pancoast | 1997 |
The effects of erythromycin on the electrocardiogram.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Electrocardiograp | 1999 |
Antimicrobial therapy for ambulatory pediatrics.
Topics: Ambulatory Care; Anti-Bacterial Agents; Anti-Infective Agents; Cefixime; Cefuroxime; Cephalexin; Cep | 1999 |
[Microbiological evaluation of antibiotics for empirical therapy of community-acquired infections of the lower respiratory tract].
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Bronchitis; Cefuroxime; Cepha | 2000 |
Eradication of endotracheal tube biofilm by nebulised gentamicin.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antib | 2002 |